Back to UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

TBIOTBIO
6 quarters

Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLCUBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in TRANSLATE BIO INC

As of its Q2 2021 13F, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS held 38,029 shares of TBIO (Translate Bio), worth $1M. UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS' 13F filings listed TBIO from Q2 2020 to Q2 2021, 5 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$335,104

Total Shares Change

-18,700

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q3
Latest
Exited
0
-100.0%
$00.0%$201.78
0
2021-Q2
Increased
38,029
+12.2%
$1M0.0%$359.82
28
2021-Q1
Decreased
33,910
-24.6%
$559,1760.0%—
0
2020-Q4
Increased
45,000
+19.4%
$829,3500.0%—
29
2020-Q3
Increased
37,700
+101.6%
$513,0970.0%—
39
2020-Q2
New
18,700
-
$335,1040.0%—
33

Other major holders of TBIO: BAUPOST GROUP LLC/MA, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used